Safety of topical dinitrochlorobenzene.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000279:Administration, Cutaneous; D000818:Animals; D003521:Cyclopropanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004137:Dinitrochlorobenzene / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007509:Irritants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D012449:Safety
D000276:Adjuvants, Immunologic; D003521:Cyclopropanes; D004137:Dinitrochlorobenzene; D007509:Irritants; C029402:diphenylcyclopropenone